665 related articles for article (PubMed ID: 10030416)
81. Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors.
Youssef E; Fontanesi J; Mott M; Kraut M; Lucas D; Mekhael H; Ben-Josef E
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):514-9. PubMed ID: 12243830
[TBL] [Abstract][Full Text] [Related]
82. Survival in soft tissue sarcoma. Prognostic variables identified by multivariate analysis.
Rööser B; Attewell R; Berg NO; Rydholm A
Acta Orthop Scand; 1987 Oct; 58(5):516-22. PubMed ID: 3425281
[TBL] [Abstract][Full Text] [Related]
83. Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas.
Fleming JB; Berman RS; Cheng SC; Chen NP; Hunt KK; Feig BW; Respondek PM; Yasko AW; Pollack A; Patel SR; Burgess MA; Papadopoulos NE; Plager C; Zagars G; Benjamin RS; Pollock RE; Pisters PW
J Clin Oncol; 1999 Sep; 17(9):2772-80. PubMed ID: 10561352
[TBL] [Abstract][Full Text] [Related]
84. Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck.
Andrä C; Rauch J; Li M; Ganswindt U; Belka C; Saleh-Ebrahimi L; Ballhausen H; Nachbichler SB; Roeder F
Radiat Oncol; 2015 Jul; 10():140. PubMed ID: 26156022
[TBL] [Abstract][Full Text] [Related]
85. Single-institution, multidisciplinary experience with surgical resection of primary chest wall sarcomas.
Kachroo P; Pak PS; Sandha HS; Lee C; Elashoff D; Nelson SD; Chmielowski B; Selch MT; Cameron RB; Holmes EC; Eilber FC; Lee JM
J Thorac Oncol; 2012 Mar; 7(3):552-8. PubMed ID: 22307013
[TBL] [Abstract][Full Text] [Related]
86. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.
Gustafson P
Acta Orthop Scand Suppl; 1994 Jun; 259():1-31. PubMed ID: 8042499
[TBL] [Abstract][Full Text] [Related]
87. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up.
Pearlstone DB; Pisters PW; Bold RJ; Feig BW; Hunt KK; Yasko AW; Patel S; Pollack A; Benjamin RS; Pollock RE
Cancer; 1999 Jan; 85(1):85-92. PubMed ID: 9921978
[TBL] [Abstract][Full Text] [Related]
88. The role of multimodality therapy in soft-tissue sarcoma.
Brennan MF; Casper ES; Harrison LB; Shiu MH; Gaynor J; Hajdu SI
Ann Surg; 1991 Sep; 214(3):328-36; discussion 336-8. PubMed ID: 1929613
[TBL] [Abstract][Full Text] [Related]
89. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
[TBL] [Abstract][Full Text] [Related]
90. An Evaluation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) Staging System for Retroperitoneal Sarcomas Using the National Cancer Data Base (NCDB): Does Size Matter?
Fisher SB; Chiang YJ; Feig BW; Cormier JN; Hunt KK; Torres KE; Roland CL
Am J Clin Oncol; 2019 Feb; 42(2):160-165. PubMed ID: 30394881
[TBL] [Abstract][Full Text] [Related]
91. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems.
Huang HY; Lal P; Qin J; Brennan MF; Antonescu CR
Hum Pathol; 2004 May; 35(5):612-21. PubMed ID: 15138937
[TBL] [Abstract][Full Text] [Related]
92. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
[TBL] [Abstract][Full Text] [Related]
93. Fast neutron radiotherapy for soft tissue and cartilaginous sarcomas at high risk for local recurrence.
Schwartz DL; Einck J; Bellon J; Laramore GE
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):449-56. PubMed ID: 11380233
[TBL] [Abstract][Full Text] [Related]
94. Wound complications are a predictor of worse oncologic outcome in extremity soft tissue sarcomas.
Dadras M; Koepp P; Wallner C; Wagner JM; Sogorski A; Lehnhardt M; Harati K; Behr B
Surg Oncol; 2020 Jun; 33():126-134. PubMed ID: 32561077
[TBL] [Abstract][Full Text] [Related]
95. Buttock soft tissue sarcoma: clinical features, treatment, and prognosis.
Behranwala KA; Barry P; A'Hern R; Thomas JM
Ann Surg Oncol; 2003 Oct; 10(8):961-71. PubMed ID: 14527918
[TBL] [Abstract][Full Text] [Related]
96. Clinical importance of late recurrence in soft-tissue sarcomas.
Gibbs JF; Lee RJ; Driscoll DL; McGrath BE; Mindell ER; Kraybill WG
J Surg Oncol; 2000 Feb; 73(2):81-6. PubMed ID: 10694643
[TBL] [Abstract][Full Text] [Related]
97. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients.
Iqbal N; Shukla NK; Deo SV; Agarwala S; Sharma DN; Sharma MC; Bakhshi S
Clin Transl Oncol; 2016 Mar; 18(3):310-6. PubMed ID: 26243399
[TBL] [Abstract][Full Text] [Related]
98. [Prognostic factors in sarcomas of the soft tissues].
Saccani Jotti G; Banadonna G
Acta Biomed Ateneo Parmense; 1986; 57(5-6):187-201. PubMed ID: 2955624
[TBL] [Abstract][Full Text] [Related]
99. Validation of the lung cancer staging system revisions using a large prospective clinical trial database (ACOSOG Z0030).
Fibla JJ; Cassivi SD; Decker PA; Allen MS; Darling GE; Landreneau RJ; McKenna RJ; Putnam JB;
Eur J Cardiothorac Surg; 2013 May; 43(5):911-4. PubMed ID: 23014970
[TBL] [Abstract][Full Text] [Related]
100. Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332.
Douglass DP; Coffin CM; Randall RL; Yang Y; Barkauskas DA; Million L; McCarville MB; Pappo AS; Weiss AR; Spunt SL
Pediatr Blood Cancer; 2024 Aug; 71(8):e31062. PubMed ID: 38757485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
